Research

ICGGC 2020

gupta.amn@gmail.com (Aman_CF) — Mon, 11 Jan 2021 16:44:15 +0530

The Indian Cancer Genetics and Genomics Conference-2020

The Indian Cancer Genetics and Genomics Conference-2020 (ICGGC-2020) was organized on a hybrid-virtual platform on the 24^th and 25^th of November 2020. This was organised by the Department of Medical Oncology, AIIMS, New Delhi in association with the Indo-UK Genetic Education Forum, under the aegis of the Research and Education Society of medical Oncology (RESMO).

Genetics and genomics are playing an ever-increasing role in deciding the management of cancers, be it the diagnosis, prognosis, precision therapeutic management or precision prevention. The role of genomics and genetics in oncology is evolving at an extremely fast pace and it is prudent to keep abreast of it. Precision prevention, particularly identifying the high-risk families and unaffected relatives has a tremendous potential for preventing cancers and altering the natural history of the disease. With this intent in mind, this conference was planned to present the current state-of -the art management in Clinical Cancer Genetics. It was an educational event targeted to the residents training in medical, surgical, radiation oncology and gynaecological and breast surgery in different institutes all over the country.

The conference had a galaxy of esteemed faculty, including renowned clinicians and geneticists from the United kingdom, the United Sates, leading academic institutes across the length and breadth of India including AIIMS-New Delhi, Tata Memorial Hospital-Mumbai, PGIMER-Chandigarh, JIPMER-Puducherry, Cancer Institute-Adyar, Chennai.

The first day was dedicated to Hereditary breast and ovarian cancers and the speakers explained the current concepts and the state- of – the art practice. Important data from European and Indian studies were presented and discussed. Panel discussion explaining the important aspects of clinical management was organised. The second day was dedicated was Lynch syndrome, Li Fraumeni, Retinoblastoma and other miscellaneous cancers. The laboratory principles, technical details of reporting, genetic counselling etc were addressed.

The event was attended online and appreciated by more than 800 viewers all over the world. The videos of the event, both days 1 & 2 are available at the link on the institute website.

Day 1:

https://drive.google.com/file/d/1vQpvHhXdpYiTrqgoV_szWZsl1eqrj12z/view?usp=sharing

Day 2:

https://drive.google.com/file/d/1ft2HFDx3pAUeWXKSt7nqDonAz2II1yev/view?usp=sharing

Dr. Deepam Pushpam

gupta.amn@gmail.com (Aman_CF) — Thu, 01 Oct 2020 11:52:03 +0530

{loadposition medical_oncology}

Name: Dr. Deepam Pushpam

Qualification: MD (Internal Medicine), DM (Medical Oncology)

Designation: Assistant Professor, Department of Medical Oncology.

Address: Room No. 245, Department of Medical Oncology 2nd Floor, Dr B.R.A-I.R.C.H, AIIMS , Ansari Nagar, New Delhi 110029.

Contact info: Email: deepampushpam@gmail.com

Academic career: Dr. Deepam Pushpam graduated from the Guwahati Medical College, Guwahati University and received his MD degree in Internal Medicine from AIIMS, Delhi. He did his senior resident ship in Medical oncology at the Dr. B. R. A- IRCH, AIIMS, New Delhi and completed his DM degree in Medical Oncology from AIIIMS. He was recruited as a faculty in Medical Oncology at the Dr. B R A –IRCH, AIIMS, New Delhi in 2018.

Area of Expertise: Dr. Deepam Pushpam is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of pediatric solid cancer, soft tissue sarcoma, melanoma, pediatric and adult hematological malignancies and hematopoietic stem cell transplant. He routinely takes care of these patients in the OPD and wards. He has keen interest in hematopoietic stem cell transplant for congenital disorders in children, cord blood transplant, allogeneic hematopoietic stem cell transplant and haploidentical stem cell transplant. He also actively participates in clinical services for lung cancer.

Research interest: Acute lymphoblastic leukemia, chronic myeloid leukemia, rare pediatric tumors, and soft tissue sarcoma.

Awards:

Geeta Mittal Award for Best Research in Oncology AIIMS, Delhi 2018.
Best Thesis in Oncology ICON 2018

Membership of Professional bodies:

1. Member: European Society for Medical Oncology, (ESMO).

2. Member: Indian Society of Medical and Paediatric Oncology,(ISMPO)

3. Member: Paediatric Hemato-Oncology chapter of Inadian Academy of Paediatrics (PHO-IAP)

Selected publications:

Pushpam, D., Bakhshi, S. Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician’s perspective. DARU J Pharm Sci (2020). doi.org/10.1007/s40199-019-00321-z
Pushpam D, Bakhshi S. Paediatric chronic myeloid leukaemia: Is it really a different disease?Indian J Med Res. 2019 May;149(5):600-609. doi: 10.4103/ijmr.IJMR_331_19. Review.
Pushpam D, Rajput N, Chopra A, Vishnubhatla S, Kumari M, Kumar R, Bakhshi S.Association of absolute lymphocyte count and peripheral blood lymphocyte subsets percentage with minimal residual disease at the end of induction in pediatric B cell acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2019 Apr;36(3):138-150. doi: 10.1080/08880018.2019.1594469. Epub 2019 May 3.
Pushpam D, Chopra A, Sreenivas V, Kumar R, Bakhshi S.Absolute Lymphocyte Count at the End of Induction as a Surrogate Marker for Minimal Residual Disease in T-cell Acute Lymphoblastic Leukemia. Pushpam D, Chopra A, Sreenivas V, Kumar R, Bakhshi S. Indian Pediatr. 2019 May 15;56(5):381-383.
Ganguly S, Pushpam D, Mian A, Chopra A, Gupta R, Bakhshi S. Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India. Clin Lymphoma Myeloma Leuk. 2020 Mar 6. pii: S2152-2650(20)30112-9. doi: 10.1016/j.clml.2020.02.015.
Kancharla H, Gundu N, Pathak N, Vandidassane I, Khurana S, Pushpam D, Jain D, Kumar S, Pathy S, Mohan A, Malik PS.Cytotoxic chemotherapy in advanced non-small cell lung cancer with poor performance status: A retrospective analysis from routine clinical practice. Curr Probl Cancer. 2020 Jan 20:100550. doi: 10.1016/j.currproblcancer.2020.100550.Review.

Dr. ATUL BATRA

1992harish.saini@gmail.com (Mr Harish Programmer) — Wed, 14 Mar 2018 10:31:59 +0530

BIOGRAPHICAL DATA

Name: Atul Batra

Address: New Delhi, India

Telephone/Email: +91-11-29575232/batraatul85@gmail.com

Present rank: Associate Professor

Department: Medical Oncology

Faculty: Medicine

Institution: All India Institute of Medical Sciences, New Delhi

Date of Birth: 02 January 1986

Major clinical interests

Dr.Batra is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of Breast cancer, and Genitourinary cancers and routinely takes care of these patients in the OPD and wards.

Major research interests

Breast Cancer
Prostate Cancer
Renal Cell Cancer
Urinary Bladder Cancer
Germ Cell Tumor

ACADEMIC RECORD

Post-Secondary Education

Institution/University

Degree

Subject/Area

Dates

Maulana Azad Medical College, Delhi University

MBBS

General Medicine and Surgery

July 2003 to December 2008

All India Institute of Medical Sciences, New Delhi

Internal Medicine

January 2009 to December 2011

All India Institute of Medical Sciences, New Delhi

Medical Oncology

January 2013 to December 2015

Tom Baker Cancer Centre,Calgary, Canada

Fellowship

Breast cancer and Health Services Research

July 2019 to June 2020

Continuing Education and Training

Institution / University	Rank or Title	Dates
Maulana Azad Medical College, Delhi University, India	Intern	January 2008 to December 2008
All India Institute of Medical Sciences, New Delhi, India	Senior Resident, Internal Medicine	January 2012 to October 2012
All India Institute of Medical Sciences, New Delhi	Senior resident, Medical Oncology	January 2016 to November 2016
Second University of Naples, Italy	Translational Research Unit Fellow	April 2016
Memorial Sloan Kettering Cancer Centre, New York, USA	nternational CML Foundation Fellow	October 2017 to November 2017
Tom Baker Cancer Centre, University of Calgary	Clinical and Research Fellow	July 2019 to present
Stanford University	Medical Statistics I-III (Certificate course)	May 2020-May 2021
All India Institute of Medical Sciences, new Delhi	Part-time Fellowship in Research Methodology and Evidence Based Medicine	January 2021-ongoing

Board Exams and Certifications

Year	Board Exam/Certificate
2015	European Society of Medical Oncology Exam
2017	Diplomate of National Board (Medical Oncology), India
2017	Membership of the Royal Colleges of Physicians of the United Kingdom Speciality Certificate Exam (Medical Oncology)
2018	Membership of the Royal Colleges of Physicians of the United Kingdom Part 1 and 2

Medical Licensure

Year	Licensing Body	Subject/Area
2008-present	Delhi Medical Council	General
2012-present	Delhi Medical Council	Specialist: Internal Medicine
2016-present	Delhi Medical Council	Specialist: Medical Oncology
2019-2020	College of Physicians and Surgeons of Alberta	Post graduate medical trainee, Medical Oncology

ACADEMIC APPOINTMENTS

University, Company or Organization	Rank or Title	Dates
All India Institute of Medical Sciences, New Delhi, India	Associate Professor	July 2020 to present
All India Institute of Medical Sciences, New Delhi, India	Assistant Professor	November 2016 to June 2020

AWARDS AND DISTINCTIONS

Year	Description	City, Country
2021	ASCO International Innovation Grant	USA
2020	Coltman Scholar Award at San Antonio Breast Cancer Symposium 2020	San Antonio, USA
2020	ASCO Merit Award in Quality Care Symposium 2020	Chicago, USA
2020	Novartis Oncology Young Canadian Investigator Award 2020	Calgary, Canada
2020	Young Investigator Award, ESMO World GI Congress 2020	Barcelona, Spain
2020	ASCO Merit Award at Annual ASCO meeting 2020	Chicago, USA
2020	ESMO Breast 2020 Merit Award- Travel Grant	Berlin, Germany
2018	President Gold Medal for the Best Diplomate of National Board in Medical Oncology	Delhi, India
2018	European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Breast Cancer	Singapore
2018	European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Prostate Cancer	Singapore
2017	International CML preceptorship award	New York, USA
2017	Young Investigator Award at International Society of Paediatric Oncology Annual Meeting	Washington DC, USA
2016	Department of Science and Technology International Travel Award	Delhi, India
2016	Multinational Association of Supportive Care in Cancer Annual Meeting Scholarship Award	Adelaide, Australia
2016	European Society of Medical Oncology (ESMO) Translational Research Fellowship Award	Naples, Italy
2016	Gold medal (Smt. Shakuntala Jolly Award) for the Best DM student in Medical Oncology at All India Institute of Medical Sciences	Delhi, India
2016	Best Clinical research (Smt. Geeta Mittal Award) in Oncology in All India Institute of Medical Sciences	Delhi, India
2015	Young Investigator Award at International Society of Paediatric Oncology Annual Meeting	Cape town, South Africa
2015	European Society of Medical Oncology (ESMO) Asia Annual Meeting Scholarship Award	Singapore
2015	European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Prostate Cancer	Prague, Czech Republic
2015	Indian Council for Medical Research International Travel Award for American Society of Clinical Oncology (ASCO) Annual Meeting	Chicago, USA
2015	European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Non-small Cell Lung Cancer	Singapore
2014	Awarded first prize in oncology quiz at International Acute Lymphoblastic Leukaemia Conference	Chennai, India
2014	European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Immuno-oncology	Barcelona, Spain

PROFESSIONAL ACTIVITIES

Current Memberships in Professional Societies

American Society of Clinical Oncology (ASCO)

Canadian Society of Medical Oncology (CAMO)

European Society of Medical Oncology (ESMO)

Indian Society of Medical and Paediatric Oncology (ISMPO)

Multinational Association for Supportive Care in Cancer (MASCC)

Invited Journal Reviews

Journal of Global Oncology

PLoS One

British Medical Journal Case Reports

Indian Journal of Medical and Paediatric Oncology

National Medical Journal of India

RESEARCH PROJECTS

Ongoing Research Projects

A. Investigator-initiated

1. Randomized double-blind placebo-controlled trial of topical 1% diclofenac in prevention of capecitabine induced hand foot syndrome

2. Assessment of serum tumor marker response in patients receiving neoadjuvant chemotherapy in triple negative breast cancer

3. Assessment of symptom burden in cancer patients through an innovative mobile-based patient-reported outcomes system in India

Industry-sponsored (PI at site)

1. A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Characterised by PTEN deficiency (CAPItello-281).

2. A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients with Unresectable Locally Advanced or Metastatic Urothelial Cancer

3. SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrazole plus Palbociclib for the Treatment of Patients with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

Completed

Year	Project	Role
2019	A multicenter phase 4, open-label, single-arm, safety and efficacy study of enzalutamide in indian patients With progressive metastatic castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy principal investigator.	Principal Investigator for site
2017	Immunohistochemical expression of sirtuin-1 in osteosarcoma and correlation with survival outcomes.	Principal Investigator
2017	A prospective, multicenter, randomized, double-blind, Parallel group study to compare the efficacy and Safety of GBR 200 (similar biologic of trastuzumab) Versus innovator trastuzumab, both when given in Combination with paclitaxel in patients diagnosed with Her2 positive metastatic breast cancer.	Co-Investigator
2017	A multicenter, open-label phase 2b study of selinexor (kpt-330) in patients with relapsed/refractory DLBCLwho have no therapeutic options of demonstrated clinical benefit.	Co-Investigator
2016	Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.	Co-Investigator
2015	Metronomic chemotherapy vs best supportive care inprogressive pediatric solid malignant tumors: a randomized clinical trial. Research Staff Shikha Jain (Junior Research Fellow) Sneha Gund (Study Coordinator) Akansha Dhakolia (Study Nurse)	Co-Investigator

INVITED ADRESSES

Year	Conference/Event	Topic	City, Country
2021	Best of SABCS New Delhi, India	CDK4/6 inhibitors in adjuvant setting in patients with breast cancer	Delhi, India
2020	Year in Review- Breast Cancer	Newer therapies in HER2 positive breast cancer	Mumbai, India
2018	Association of Breast Surgeons of India annual conference	Optimizing adjuvant treatment in early breast cancer patients	Delhi, India
2018	International Precision Oncology & Breast Cancer Conference	Role of comprehensive genomic sequencing in metastatic breast cancer	Jaipur, India
2018	Best of San Antonio Breast Cancer Symposium	Developments in metastatic hormone positive breast cancer in 2017	Delhi, India
2018	Treating Breast Cancer with Precision	Optimizing neoadjuvant chemotherapy in HER2 positive breast cancer	Chennai, India
2018	Updates in Breast Cancer by National Cancer Institute	Contemporary management of early triple negative breast cancer: Medical Oncologist’s perspective	Delhi, India
2018	Year in Review: Genitourinary Cancers	Sequencing of treatment in metastatic prostate cancer	Kolkata, India
2017	Updates in Gynaecological Cancers by National Cancer Institute	Role of bevacizumab in cervical cancer	Delhi, India
2017	Indian Gastrointestinal Oncology Meet	Advances in treatment of metastatic colon cancer	Mumbai, India
2017	Advances in Haematology	Stopping Imatinib in CML: Is this the right time?	Delhi, India
2017	36^th ICON conference	Immunotherapy in renal cell cancer: A new era	Lucknow, India

PUBLICATIONS AND PRESENTATIONS

PubMed Indexed Publications

Sharma A, Sahoo RK, Batra A. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med. 2021 Nov 11;385(20):1919. doi: 10.1056/NEJMc2115204. PMID: 34758261.
Blomstrand H, Batra A, Cheung WY, Elander NO. Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer. World J Clin Oncol. 2021 Sep 24;12(9):787-799. doi: 10.5306/wjco.v12.i9.787. PMID: 34631442; PMCID: PMC8479347.
Mittal A, Deo SVS, Gogia A, Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Thulkar S, Ramprasad VL, Olopade O, Pramanik R. Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center. Ann Surg Oncol. 2021 Oct 2:1–10. doi: 10.1245/s10434-021-10870-w. Epub ahead of print. PMID: 34601666; PMCID: PMC8487333.
Batra A, Yusuf D, Hurry M, Walton RN, Devost N, Farrer C, Cheung WY. A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non-Small Cell Lung Cancer. Am J Clin Oncol (e-pub ahead of print 11 August 2021; doi:10.1097/COC.0000000000000857)
Batra A, Tang PA, Cheung WY. Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy. Am J Clin Oncol (e-pub ahead of print 9 August 2021; doi:10.1097/COC.0000000000000856).
Gupta N, Gupta A, Sarma R, Batra A, Madan K. Video laryngoscopy vs. direct laryngoscopy for nasotracheal intubation in oro-maxillofacial surgery: a systematic review and meta-analysis of randomized controlled trials. Korean J Anesthesiol (e-pub ahead of print 9 August 2021; doi:10.4097/kja.21234).
Batra A, Kong S, Cheung WY. Associations of Socioeconomic Status and Rurality With New-Onset Cardiovascular Disease in Cancer Survivors: A Population-Based Analysis. JCO Oncol Pract. 2021 Jul 9:OP2001053. doi: 10.1200/OP.20.01053. Epub ahead of print. PMID: 34242068.
Amaro CP, Batra A, Lupichuk S. First-Line Treatment with a Cyclin-Dependent Kinase 4/6 Inhibitor Plus an Aromatase Inhibitor for Metastatic Breast Cancer in Alberta. Current Oncology 2021; 28: 2270–2280. [DOI: 10.3390/curroncol28030209]
Batra A, Nixon NA, Roldan-Urgoiti G, Hannouf MB, Abedin T, Hugh J, King K, Bigras G, Steed T, Lupichuk S. Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer. Cancer Treat Res Commun 2021; 28: 100401. [PMID: 34091374 DOI: 10.1016/j.ctarc.2021.100401]
Batra A, Yang L, Boyne DJ, Harper A, Cuthbert CA, Cheung WY. Symptom burden in patients with common cancers near end-of-life and its associations with clinical characteristics: a real-world study. Support Care Cancer 2021; 29: 3299–3309. [PMID: 33104922 DOI: 10.1007/s00520-020-05827-w]
Singh TP, Sharma A, Sharma A, Bakhshi S, Patel C, Pandey AK, Dhamija E, Batra A, Kumar R. Utility of 18F-FDG-PET/CT in management and prognostication of treatment naïve late-stage soft tissue sarcomas. Nucl Med Commun 2021; 42: 818–825. [PMID: 33741856 DOI: 10.1097/MNM.0000000000001401]
Batra A, Rigo R, Hannouf MB, Cheung WY. Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer. Clin Colorectal Cancer 2021; 20: e75–e81. [PMID: 33268287 DOI: 10.1016/j.clcc.2020.09.006]
Yadav S, Mathew R, Sahu AK, Jamshed N, Mohindra R, Aggarwal P, Batra A, Halder D, Brunda RL. Prognostic Value of Serum Procalcitonin Levels in Patients With Febrile Neutropenia Presenting to the Emergency Department. J Emerg Med 2021; 60: 641–647. [PMID: 33518374 DOI: 10.1016/j.jemermed.2020.12.010]
Batra A, Cheung WY. Role of real-world evidence in informing cancer care: lessons from colorectal cancer. Curr Oncol 2019; 26: S53–S56. [PMID: 31819710 DOI: 10.3747/co.26.5625]
Patel A, Gupta VG, Biswas B, Ganguly S, Das CK, Batra A, Bhethanabhotla S. Reply to D. O’Reilly et al. JCO Glob Oncol 2021; 7: 648. [PMID: 33956500 DOI: 10.1200/GO.21.00077]
Hannouf M, Batra A, Lupichuk S. Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008-2012. Curr Oncol 2021; 28: 1137–1142. [PMID: 33806441 DOI: 10.3390/curroncol28020109]
Boyne DJ, Cheung WY, Hilsden RJ, Sajobi TT, Batra A, Friedenreich CM, Brenner DR. Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer. JAMA Netw Open 2021; 4: e213587. [PMID: 33783516 DOI: 10.1001/jamanetworkopen.2021.3587]
Arora S, Kumar A, Batra A. Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Early Triple-Negative Breast Cancer. JAMA Oncol 2021; 7: 460–461. [PMID: 33410889 DOI: 10.1001/jamaoncol.2020.7157]
Batra A, Yang L, Boyne DJ, Harper A, Cheung WY, Cuthbert CA. Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer. Support Care Cancer 2021; 29: 1423–1431. [PMID: 32676854 DOI: 10.1007/s00520-020-05623-6]
Batra A, McKinnon G, Billawala A, Sheka D, Kong S, Cheung WY. Factors associated with the initiation of chemotherapy within 90 days of death in metastatic colorectal cancer patients: a population-based study. Support Care Cancer 2021; 29: 1535–1542. [PMID: 32725376 DOI: 10.1007/s00520-020-05655-y]
Batra A, Kumar A. HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic? Breast 2021; 55: 136. [PMID: 33328129 DOI: 10.1016/j.breast.2020.11.017]
Singh N, Batra A, Yang L, Boyne DJ, Harper A, Ghatage P, Cuthbert CA, Cheung WY. Patient-Reported Symptom Burden Near the End of Life in Patients With Gynaecologic Cancers. J Obstet Gynaecol Can 2021; 43: 26–33. [PMID: 32967796 DOI: 10.1016/j.jogc.2020.06.017]
Patel A, Gupta VG, Biswas B, Das CK, Batra A, Ganguly S, Bhethanabhotla S. Revisiting Fulvestrant Dosing in Uncertain Economic Times. JCO Glob Oncol 2021; 7: 1–3. [PMID: 33405958 DOI: 10.1200/GO.20.00362]
Batra A. Platelet Normalized Serum Vascular Endothelial Growth Factor Levels in Progressive Pediatric Solid Malignancies. Indian Pediatr 2020; 57: 1188.
Singh N, Al-Ruwaisan M, Batra A, Itani D, Ghatage P. Factors Affecting Overall Survival in Premenopausal Women With Uterine Leiomyosarcoma: A Retrospective Analysis With Long-Term Follow-Up. J Obstet Gynaecol Can 2020; 42: 1483–1488. [PMID: 32900677 DOI: 10.1016/j.jogc.2020.05.016]
Batra A, Kong S, Cheung WY. Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials. Clin Colorectal Cancer 2020; 19: e226–e234. [PMID: 32636076 DOI: 10.1016/j.clcc.2020.05.005]
Batra A, Kong S, Cheung WY. Eligibility of real-world patients with metastatic breast cancer for clinical trials. Breast 2020; 54: 171–178. [PMID: 33120082 DOI: 10.1016/j.breast.2020.10.005]
Batra A, Hannouf MB, Alsafar N, Lupichuk S. Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study. Breast 2020; 54: 1–7. [PMID: 32861882 DOI: 10.1016/j.breast.2020.08.002]
Batra A, Sheka D, Kong S, Cheung WY. Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer. BMC Cancer 2020; 20: 1004. [PMID: 33059611 DOI: 10.1186/s12885-020-07487-9]
Vanidassane I, Dhamija E, Naik SS, Batra A. An unusual durable response with palbociclib plus letrozole in hormone receptor positive metastatic breast cancer after multiple lines of therapy. Indian J Cancer 2020; 57: 348–350. [PMID: 32769294 DOI: 10.4103/ijc.IJC_66_19]
Ding PQ, Batra A, Xu Y, McKinnon GP, Cheung WY. Obesity and Its Impact on Outcomes in Patients With Stage III Colon Cancer Receiving Adjuvant Chemotherapy. Clin Colorectal Cancer 2020; 19: 209–218. [PMID: 32291245 DOI: 10.1016/j.clcc.2020.02.010]
Bosma NA, Tilley D, Batra A, Cheung WY. Characterizing Urban-Rural Differences in Colon Cancer Outcomes: A Population-based Analysis Based on Travel Distance to Cancer Center. Am J Clin Oncol 2020; 43: 531–535. [PMID: 32324599 DOI: 10.1097/COC.0000000000000703]
Batra A, Rigo R, Sheka D, Cheung WY. Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer. World J Gastrointest Oncol 2020; 12: 604–618. [PMID: 32699576 DOI: 10.4251/wjgo.v12.i6.604]
Vanidassane I, Naik RD, Sharma V, Khurana S, Batra A. Adjuvant trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: Take-home points from the KATHERINE trial. Natl Med J India 2020; 33: 158–159. [PMID: 33904420 DOI: 10.4103/0970-258X.314006]
Patel A, Tannock IF, Srivastava P, Biswas B, Gupta VG, Batra A, Bhethanabhotla S, Pramanik R, Mahindru S, Tilak T, Das CK, Mehta P. Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. JCO Glob Oncol 2020; 6: 382–386. [PMID: 32125899 DOI: 10.1200/JGO.19.00341]
Baa AK, Naik RD, Vanidassane I, Arora S, Shamim SA, Mallick S, Batra A. Unusual Gastric Metastasis in Triple-Negative (Estrogen Receptor/Progesterone Receptor/HER2neu Negative) GATA-Binding Protein 3-Positive Breast Cancer. Indian J Nucl Med 2020; 35: 82–83. [PMID: 31949382 DOI: 10.4103/ijnm.IJNM_156_19]
Mian A, Kumari K, Kaushal S, Fazal F, Kodan P, Batra A, Kumar P, Baitha U, Jorwal P, Soneja M, Sharma MC, Biswas A. Fatal familial hemophagocytic lymphohistiocytosis with perforin gene (PRF1) mutation and EBV-associated T-cell lymphoproliferative disorder of the thyroid. Autops Case Rep 2019; 9: e2019101. [PMID: 31440481 DOI: 10.4322/acr.2019.101]
Mittal A, Batra A. Adjuvant chemotherapy in early breast cancer: Are we over-treating patients? Natl Med J India 2019; 32: 230–231. [PMID: 32769244 DOI: 10.4103/0970-258X.291305]
Batra A, Patel A, Gupta VG, Mehta P, Tvsvgk T, Biswas B, Pramanik R, Das CK, Srivastava P. Oncotype DX: Where Does It Stand in India? J Glob Oncol 2019; 5: 1–2. [PMID: 31310569 DOI: 10.1200/JGO.19.00151]
Vanidassane I, Sharma V, Ramteke P, Yadav MK, Batra A. Primary Yolk Sac Tumor of the Liver in an Adult Man. ACG Case Rep J 2019; 6: e00050. [PMID: 31616734 DOI: 10.14309/crj.0000000000000050]
Naik RD, Batra A, Gupta VG. Palbociclib and Fulvestrant in Breast Cancer. N Engl J Med 2019; 380: 796. [PMID: 30786199 DOI: 10.1056/NEJMc1816595]
Patekar M, Adhikari N, Biswas A, Raina V, Kumar L, Mohanti BK, Gogia A, Sharma A, Batra A, Bakhshi S, Garg A, Thulkar S, Sharma MC, Vishnubhatla S, Baghmar S, Sahoo RK. Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences. J Glob Oncol 2019; 5: 1–9. [PMID: 30811305 DOI: 10.1200/JGO.18.00124]
Vanidassane I, Mittal A, Kumar C, Tanwar P, Sahoo RK, Batra A. Skin metastasis: a rare presentation in testicular germ cell tumour. BMJ Case Rep 2018; 2018. [PMID: 30249738 DOI: 10.1136/bcr-2018-226385]
Biswas B, Ganguly S, Ghosh J, Batra A. Cisplatin-induced hearing loss in children with cancer. Natl Med J India 2017; 30: 327–328. [PMID: 30117444 DOI: 10.4103/0970-258X.239073]
Pramanik R, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Batra A, Dhawan D, Bakhshi S. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial. JAMA Oncol 2017; 3: 1222–1227. [PMID: 28384657 DOI: 10.1001/jamaoncol.2017.0324]
Srivastava R, Batra A, Dhawan D, Bakhshi S. Association of energy intake and expenditure with obesity: A cross-sectional study of 150 pediatric patients following treatment for leukemia. Pediatr Hematol Oncol 2017; 34: 29–35. [PMID: 28287332 DOI: 10.1080/08880018.2016.1272025]
Batra A, Kashyap S, Singh L, Bakhshi S. Expression of FOXO3a and Correlation With Histopathologic Features in Retinoblastoma. Appl Immunohistochem Mol Morphol 2017; 25: 95–99. [PMID: 26574636 DOI: 10.1097/PAI.0000000000000278]
Biswas B, Rastogi S, Batra A, Ganguly S. Trastuzumab and lapatinib in HER2-positive metastatic colorectal cancer. Natl Med J India 2016; 29: 219–220.
Dabas A, Batra A, Khadgawat R, Jyotsna VP, Bakhshi S. Growth and Endocrinal Abnormalities in Pediatric Langerhans Cell Histiocytosis. Indian J Pediatr 2016; 83: 657–660. [PMID: 26988579 DOI: 10.1007/s12098-016-2053-y]
Batra A, Kain R, Kumari M, Paul R, Dhawan D, Bakhshi S. Parents’ Perspective of Quality of Life of Retinoblastoma Survivors. Pediatr Blood Cancer 2016; 63: 1287–1289. [PMID: 27038275 DOI: 10.1002/pbc.25982]
Batra A, Kumari M, Paul R, Patekar M, Dhawan D, Bakhshi S. Quality of Life Assessment in Retinoblastoma: A Cross-Sectional Study of 122 Survivors from India. Pediatr Blood Cancer 2016; 63: 313–317. [PMID: 26488435 DOI: 10.1002/pbc.25781]
Batra A, Kashyap S, Singh L, Bakhshi S. Sirtuin1 Expression and Correlation with Histopathological Features in Retinoblastoma. Ocul Oncol Pathol 2015; 2: 86–90. [PMID: 27172132 DOI: 10.1159/000439594]
Nataraj V, Batra A, Rastogi S, Khan SA, Sharma MC, Vishnubhatla S, Bakhshi S. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients. J Surg Oncol 2015; 112: 662–668. [PMID: 26381138 DOI: 10.1002/jso.24045]
Batra A, Thakar A, Bakhshi S. Ototoxicity in retinoblastoma survivors treated with carboplatin based chemotherapy: A cross-sectional study of 116 patients. Pediatr Blood Cancer 2015; 62: 2060. [PMID: 26053139 DOI: 10.1002/pbc.25618]
Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V. Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial. Support Care Cancer 2015; 23: 3229–3237. [PMID: 25851802 DOI: 10.1007/s00520-015-2714-9]
Batra A, Bakhshi S. Aprepitant for paediatric chemotherapy-induced nausea and vomiting. Lancet Oncol 2015; 16: e259-260. [PMID: 26065606 DOI: 10.1016/S1470-2045(15)70244-5]
Singh N, Tripathi R, Mala Y, Batra A. Diagnostic Dilemma in Cornual Pregnancy- 3D Ultrasonography may Aid!! J Clin Diagn Res 2015; 9: QD12-13. [PMID: 25738045 DOI: 10.7860/JCDR/2015/6775.5484]
Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, Pramanik R, Gupta R. Complete response after autologous stem cell transplant in multiple myeloma. Cancer Med 2014; 3: 939–946. [PMID: 24777883 DOI: 10.1002/cam4.257]
Batra A, Pushker N, Venkatesh P, Arora T, Tewari R, Bakhshi S. Long-term visual outcomes in intraocular retinoblastoma with eye preservation. Clin Transl Oncol 2016; 18: 1034–1038. [PMID: 26781471 DOI: 10.1007/s12094-016-1482-4]
Batra A, Patekar M, Bakhshi S. Short stature in retinoblastoma survivors: a cross-sectional study of 138 patients. Clin Transl Oncol 2016; 18: 381–384. [PMID: 26286069 DOI: 10.1007/s12094-015-1380-1]
Singh N, Tripathi R, Tyagi S, Batra A. Antepartum fetal bladder rupture leading to urinary ascitis: attempt to rescue by placement of peritoneo-amniotic shunt. BMJ Case Rep 2013; 2013. [PMID: 23946514 DOI: 10.1136/bcr-2013-200021]
Singh N, Tripathi R, Mala YM, Dixit R, Tyagi S, Batra A. Comparison of scar thickness measurements using trans-vaginal sonography and MRI in cases of pregnancy with previous caesarean section. Do they correlate with actual scar thickness? Journal of Obstetrics and Gynaecology 2013; 33: 810–813. [PMID: 24219719 DOI: 10.3109/01443615.2013.823926]
Soneja M, Batra A, Vikram NK, Ahuja A, Mohan A, Sood R. Actinomycosis and nocardiosis co-infection in chronic granulomatous disease. J Assoc Physicians India 2012; 60: 66–68.
Gupta S, Singh S, Sarkar S, Batra A. Development and validation of the ethical challenges in clinical situations-questionnaire (ECCS-Q) by involving health-care providers from a tertiary care health setting. Clinical Ethics. April 2021. doi:10.1177/14777509211011427
Dabkara D, Ganguly S, Ghosh J, Patel A, Batra A, Das CK, et al. How We Treat Genitourinary Cancers During COVID-19 Pandemic? 1 2020;5:147–52. https://doi.org/10.31557/apjcc.2020.5.S1.147-152.
Ghosh J, Ganguly S, Biswas B, Dabkara D, Srivastava P, Patel A, et al. Systemic treatment of gastroesophageal cancer during SARS-CoV2. Indian Journal of Medical and Paediatric Oncology 2020;41:141. https://doi.org/10.4103/ijmpo.ijmpo_118_20.
Bhethanabhotla S, Pramanik R, Srivastava P, Mehta P, Patel A, Biswas B, et al. Colorectal cancer chemotherapy during COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology 2020;41:156. https://doi.org/10.4103/ijmpo.ijmpo_149_20.
Pramanik R, Srivastava P, Sharma A, Mehta P, Patel A, Bhethanbhotla S, et al. Management of head-and-neck cancer during COVID-19 crisis: A medical oncology perspective. Indian Journal of Medical and Paediatric Oncology 2020;41:153. https://doi.org/10.4103/ijmpo.ijmpo_134_20.
Mahindru S, Das CK, Patel A, Mehta P, Biswas B, Batra A, et al. Cancer surgery in challenging time of COVID-19 pandemic – A pragmatic approach. Indian Journal of Medical and Paediatric Oncology 2020;41:144. https://doi.org/10.4103/ijmpo.ijmpo_121_20.
Das CK, Mahindru S, Patel A, Batra A, Biswas B, Mehta P, et al. How I treat epithelial ovarian cancer during COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology 2020;41:138. https://doi.org/10.4103/ijmpo.ijmpo_112_20.
Batra A, Mehta P, Patel A, Bhethanabhotla S, Biswas B, Pramanik R, et al. Breast cancer treatment during the COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology 2020;41:135. https://doi.org/10.4103/ijmpo.ijmpo_111_20.
Patel A, Batra A, Mehta P, Sharma A, Sirohi B, Biswas B, et al. Gallbladder cancer: Adjuvant and palliative treatment during Covid-19 pandemic in India. Indian Journal of Medical and Paediatric Oncology 2020;41:132. https://doi.org/10.4103/ijmpo.ijmpo_110_20.
Biswas B, Ganguly S, Dabkara D, Ghosh J, Srivastava P, Mehta P, et al. How we treat lung cancer during SARS-Cov-2 (COVID-19) pandemic in India? Indian Journal of Medical and Paediatric Oncology 2020;41:149. https://doi.org/10.4103/ijmpo.ijmpo_122_20.
Mehta P, Parikh P, Aggarwal S, Batra A, Patel A, Kulkarni P, et al. Has India met this enemy before? From an eternal optimist’s perspective: SARS-CoV-2. IJMS 2020;72:8–12. https://doi.org/10.25259/IJMS_30_2020.
Parikh P, Mehta P, Bansal S, Aggarwal S, Patel A, Batra A, et al. Protecting health-care professionals and workers (other than COVID-19 management facilities) from contamination during COVID-19 pandemic (March 26, 2020 – India). IJMS 2020;72:3–4. https://doi.org/10.25259/IJMS_28_2020.
Sharma A, Mittal A, Barwad A, Mridha AR, Venkatesan S, Sahoo RK, et al. Recurrent germ cell tumour presenting as fractured neck of the femur: Journal of Clinical Urology 2019. https://doi.org/10.1177/2051415819841964.
Pushpam D, Raj A, Batra A, Bakhshi S. Occam’s razor versus Hickam’s dictum: An unusual cause of acute renal failure in pediatric solid malignancy. Indian Journal of Medical and Paediatric Oncology 2019;40:445. https://doi.org/10.4103/ijmpo.ijmpo_54_18.
Patel A, Tilak TV, Gupta VG, Batra A, Mehta P, Parikh P, et al. Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advanced breast cancer. Indian Journal of Medical and Paediatric Oncology 2019;40:311. https://doi.org/10.4103/ijmpo.ijmpo_111_19.
Mehta P, Batra A, Patel A. Commentary on oncotype Dx. Indian Journal of Medical and Paediatric Oncology 2019;40:434. https://doi.org/10.4103/ijmpo.ijmpo_226_19.
Pramanik R, Kancharla H, Bakhshi S, Sharma A, Gogia A, Malik P, Sahoo RK, Batra A, Thulkar S, Kumar L. Engraftment Syndrome: A Retrospective Analysis of the Experience at a Tertiary Care Institute. Clinical Hematology International 2019; 1: 114–119. [DOI: 10.2991/chi.d.190504.001]

ABSTRACTS

Batra A, Kong S, Rigo R, Cheung WY. Impact of preexisting cardiovascular disease (CVD) on treatments and outcomes of patients with breast or lung cancer. JCO. 2020;38(15_suppl):12063-12063. doi:10.1200/JCO.2020.38.15_suppl.12063
Batra A, Cuthbert CA, Harper A, et al. Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) of patients with metastatic cancer. JCO. 2020;38(15_suppl):12020-12020. doi:10.1200/JCO.2020.38.15_suppl.12020
Batra A, Kong S, Rigo R, Cheung W. 150P Eligibility of real-world patients with metastatic breast cancer in clinical trials. Annals of Oncology. 2020;31:S70. doi:10.1016/j.annonc.2020.03.250
Batra A, Cuthbert C, Rigo R, et al. 187P Patient-reported outcomes near end-of-life in patients with breast cancer. Annals of Oncology. 2020;31:S84. doi:10.1016/j.annonc.2020.03.126
Rigo R, Koczka K, Batra A, Cheung WY, Monzon JG, Cheng T. Adjuvant systemic therapies for melanoma in Alberta: An early descriptive analysis of population characteristics and treatment outcomes. JCO. 2020;38(15_suppl):e22013-e22013. doi:10.1200/JCO.2020.38.15_suppl.e22013
Peng J, Batra A, Cheung WY. Referral-to-treatment attrition and its impact on outcomes of patients with advanced gastroesophageal cancers. JCO. 2020;38(15_suppl):e16504-e16504. doi:10.1200/JCO.2020.38.15_suppl.e16504
Cheung WY, Rigo R, Batra A. Use of Twitter among cancer clinicians and researchers and the associations with scientific impact of its users and followers. JCO. 2020;38(15_suppl):e14101-e14101. doi:10.1200/JCO.2020.38.15_suppl.e14101
Batra A, Kong S, Cheung WY. Eligibility of real-world patients with stage II/III colorectal cancer (CRC) in adjuvant chemotherapy (AC) trials. JCO 2020;38:50–50 [DOI: 10.1200/JCO.2020.38.4_suppl.50]
Batra A, Cheung WY, Tang PA. Real-world eligibility of advanced pancreatic (APC) patients for maintenance olaparib. JCO 2020;38:653–653 [DOI: 10.1200/JCO.2020.38.4_suppl.653]
Mayank Singh, Atul Batra, Sameer Bakhshi, Matthew Summers. Validation of Ubiquitin specific peptidases 37 as a prognostic and diagnostic marker in osteosarcoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1256.
Batra A, Dhawan D, Paul R, Kumari M, Bakhshi S.Improvement in Compliance of Patients with Non-Metastatic Retinoblastoma with Low-Cost Prospective Database and Patient Tracking System: A Study from Tertiary Care Centre in India. Pediatric Blood & Cancer. Volume 64, Issue S3, November 2017. Version of Record online : 1 Sep 2017, doi: 10.1002/pbc.26772
Biswas B, Jha A, Batra A, Sengupta M, Bakhshi S. Pretreatment neutrophilto lynphocyte ratio in ewing sarcoma family of tumors: An analysis of 570 patients. JCO 2017;35:e22504–e22504 [DOI: 10.1200/JCO.2017.35.15_suppl.e22504]
Pramanik R, Batra A, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Dhawan D, Bakhshi S. Progressive Paediatric Solid Tumours other than Bone-Sarcomas Benefit from Metronomic Chemotherapy: A Subgroup Analysis from a Double Blind Placebo Controlled Randomized Study. SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321.doi:10.1002/pbc.26233.
Batra A, Bakhshi S, Pushker N.Prognostic Factors in Metastatic Retinoblastoma: A Study of 70 Metastatic Retinoblastoma Patients Treated at a Single Centre in India. SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321. doi:10.1002/pbc.26233.
Batra A, Kashyap S, Pushker N, Meel R, Bakhshi S. Retinoblastoma in Children Older Than 6 Years: A Single Centre Study of 58 Patients from India. SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321. doi:10.1002/pbc.26233.
Batra A, Pushker N, Venkatesh N, Arora T, Tewari R, Bakhshi S. Correlation of Quality of Life and Visual Acuity in Survivors of Bilateral Retinoblastoma Managed with Enucleation of One Eye and Salvage of Other Eye. Support Care Cancer (2016) 24(Suppl 1): 1. https://doi.org/10.1007/s00520-016-3209-z.
Pramanik R, Bakhshi S, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Batra A, Dhawan D. Metronomic therapy versus best supportive care in progressive pediatric solid malignancies: A double blind placebo controlled randomized study. JCO 2016;34:10520–10520 [DOI: 10.1200/JCO.2016.34.15_suppl.10520]
Batra A, Kumari M, Paul R, Dhawan D , Bakhshi S. Quality of life in retinoblastoma: Quality of life assessment in retinoblastoma: A cross-sectional study of 122 survivors.10.1200/jco.2015.33.15_suppl.10068 Journal of Clinical Oncology 33, no. 15_suppl (May 2015) 10068-10068.
Batra A, Pushker N, Venkatesh N, Bakhshi S. Visual outcomes and ocular coherence tomography in patients with intraocular retinoblastoma with eye preservation. Annals of Oncology, Volume 26, Issue suppl_9, 1 December 2015, Pages ix156, https://doi.org/10.1093/annonc/mdv535.02.
Bakhshi S, Batra A, Kumari M, Paul R, Patekar M, Dhawan D. Parents’ Perspective Of Quality Of Life In Retinoblastoma Survivors: A Cross-Sectional Study Of 122 Patients. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715.
Batra A, Kashyap S, Singh L, Bakhshi S. Cytoplasmic Expression of Foxo3a in Retinoblastoma Predicts High Risk Histopathological Features. A Cross-Sectional Study Of 122 Patients. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715.
Batra A, Kashyap S, Singh L, Bakhshi S. Sirtuin1 Expression and Correlation with Histopathological Features In Retinoblastoma. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715.
Batra A, Thakar A, Patekar M, Bakhshi S. Long-term non-visual outcomes in retinoblastoma survivors SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715.
Batra A, Shrivastava R, Tyagi A , Dhawan D, Ramakrishnan L, Bakhshi S. An Insight Into The Biomarkers Of Obesity In Survivors Of Acute Leukemia. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014. Pediatr Blood Cancer, 61: S105–S433. doi:10.1002/pbc.25314.
Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V. Aprepitant As An Add-On Therapy In Children Receiving Highly Emetogenic Chemotherapy: A Randomized, Double Blind, Placebo-Controlled Trial. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014. Pediatr Blood Cancer, 61: S105–S433. doi:10.1002/pbc.25314.

Presentations

Year	Conference/Venue	Abstract(s)	Presentation (Award)
2020	ESMO Annual Congress	i. Association of pre-existing cardiovascular disease (CVD) in older patients with breast cancer with treatment and survival outcomes ii. Determinants of new onset cardiovascular disease (CVD) in cancer patients	Mini-oral E-Poster
2020	ESMO World Congress on Gastrointestinal cancers Barcelona, Spain	Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) of patients with metastatic gastrointestinal (GI) cancer Patient-reported outcomes in patients with gastric and esophageal cancers near end-of-life	Poster discussion (Young Investigator Award) Poster
2020	ASCO Annual meeting 2020, Chicago, USA	Impact of preexisting cardiovascular disease (CVD) on treatments and outcomes of patients with breast or lung cancer. Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) of patients with metastatic cancer.	Poster (ASCO Merit Award) Poster discussion
2020	ESMO Breast 2020, Berlin, Germany	Patient-reported outcomes near end-of-life in patients with breast cancer Eligibility of real-world patients with metastatic breast cancer in clinical trials	Poster Poster (Merit Award)
2020	Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting, Seville, Spain (Accepted, to be presented)	Impact of pre-existing cardiovascular disease on treatment patterns and outcomes in patients with lung cancer Physical and psychological symptom burden near end of life in patients with lung cancer using patient-reported outcomes	Eposter Eposter
2020	Canadian Association of Medical Oncology (CAMO) Annual Meeting, Toronto, Canada(Accepted, to be presented)	Eligibility of real-world patients with stage II/III colorectal cancer in adjuvant chemotherapy trials	Oral
2020	American Society of Clinical Oncology (ASCO) GI Symposium, San Francisco, USA	Eligibility of real-world patients with stage II/III colorectal cancer in adjuvant chemotherapy trials. Real-world eligibility of advanced pancreatic patients for maintenance olaparib	Poster Poster
2017	International Society of Paediatric Oncology (SIOP) Annual Meeting, Washington DC, USA	Improvement in compliance of patients with non-metastatic retinoblastoma with low-cost prospective database and patient tracking system: a study from tertiary care centre in India.	Oral, Young Investigator Award
2016	SIOP Annual Meeting, Dublin, Ireland	Prognostic factors in metastatic retinoblastoma: a study of 70 metastatic retinoblastoma patients treated at a single centre in India Retinoblastoma in children older than 6 years: a single centre study of 58 patients from India	E-poster
2016	MASCC, Adelaide, Australia	Correlation of quality of life and visual acuity in survivors of bilateral retinoblastoma managed with enucleation of one eye and salvage of other eye	Oral, Travel Scholarship Award
2015	ASCO Annual Meeting, Chicago, USA	Quality of life assessment in retinoblastoma: a cross-sectional study of 122 survivors.	Poster, ICMR Travel Award
2015	ESMO Asia, Singapore	Visual outcomes and ocular coherence tomography in patients with intraocular retinoblastoma with eye preservation.	Poster ESMO Travel Award
2015	SIOP Annual Meeting, Capetown, South Africa	Long-term non-visual outcomes in retinoblastoma survivors Expression of Foxo3a in Retinoblastoma Predicts High Risk Histopathological Features. A Cross-Sectional Study Of 122 Patients. Sirtuin1 Expression and Correlation with Histopathological Features In Retinoblastoma.	Oral Young Investigator Award E-poster E-poster
2014	SIOP Annual Meeting, Toronto, Canada	An insight into the biomarkers of obesity in survivors of acute leukaemia.	Poster

PhD Alumini

1992harish.saini@gmail.com (Mr Harish Programmer) — Tue, 13 Mar 2018 16:41:30 +0530

S.No	Names	Month & Year of PhD Awarded
1	Dr. Gottemukkala Muralik Raju	February-1999
2	Dr. Ashutosh Pathak	May-2002
3	Dr. Pratibha Sharma	January-2010
4	Dr. Rashmi Bhardwaj	September-2010
5	Dr. Rakesh Verma	March-2011
6	Dr. Nitin Mathur	February-2012
7	Dr. Surender Kumar Sharawat	May-2013
8	Dr. Nivedita Pathak	September-2013
9	Dr. Minakshi Mann	February 2014 – July 2020
10	Dr. Anudishi Tyagi	January 2013 - February 2019
11	Dr. Shivali Jasrotia	August 2011 - July 2019
12	Dr. Mohsin Maqbool	February 2010 - December 2018
13	Dr. Shilpi Chaudhary	February 2016- October 2021
14	Dr. Anjali Mookerjee	February 2015 - December 2021
15	Dr. Luxmi Devi	February 2015- February 2022

Dr Lalit Kumar

pinki.aiims@gmail.com (Ms. Pinki_CF) — Mon, 29 Jan 2018 11:00:41 +0530

Dr Lalit Kumar, MD; DM

Professor and Head

Department of Medical Oncology

All India Institute of Medical sciences

(Dr BRA Institute Rotary Cancer Hospital)

New Delhi 110029, India

E-Mail: medoncoaiims@gmail.com

Research Interests

Blood stem cell /Bone marrow transplantation
Hematological malignancies, (Multiple myeloma , chronic myeloid leukaemia, Infections)
Gynaecological malignancies: Role of neo-adjuvant Chemotherapy

Dr. Raja Pramanik

pinki.aiims@gmail.com (Ms. Pinki_CF) — Thu, 11 Jan 2018 15:04:52 +0530

Name–Dr. Raja Pramanik

Qualification: MD (Internal Medicine), DM (Medical Oncology)

Designation- Assistant Professor, Department of Medical Oncology

Address- Room No. 216, Department of Medical Oncology, 2^nd Floor, Dr B.R.A-I.R.C.H ,AIIMS , Ansari Nagar, New Delhi 110029

Contact Info :Email – drrajapramanik@gmail.com

Academic Career – Dr. Raja Pramanik graduated from the R.G.Kar Medical College of Calcutta University and received his MD degree in Internal Medicine from Patna Medical College, Patna University. He did his senior resident ship in Medical oncology at theDr. B. R. A- IRCH, AIIMS, New Delhi and completed his DM degree in Medical Oncology from AIIIMS. He was recruited as a faculty in Medical Oncology at the Dr. B R A –IRCH, AIIMS, New Delhi in 2016. Caring for cancer patients, research to improve their care and clinical teaching are his greatest passions.

Area of Expertise- Dr.Pramanik is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of the Gastro-intestinal cancers (e.g. cancers in the esophagus, stomach, liver, gall bladder, Colon and rectum) and Head and Neck cancers and routinely takes care of these patients in the OPD and wards. He also has keen interest in Clinical Cancer genetics, genetic counselling and research. He also actively participates in clinical services for adult haematological malignancies e.g. Hodgkins lymphoma, NHL, Acute and Chronic Leukemias and Multiple myeloma.

Research Interests:Esophageal cancer, Clinical Cancer genetics, immuno-oncology, Translational oncology, Metronomic chemotherapy.

Awards-

1. Received the prestigious “Brigid Leventhal Merit Award” in June 2016 at the Annual meeting of American Society of Clinical Oncology(ASCO), in Chicago for the best abstract in Paediatric Oncology by a fellow, as determined by the Program

Committee's Paediatrics Subcommittee.

2. Received IDEA Award (International Development and Education Award) 2016 from American Society of Clinical Oncology, in Chicago, June 2016.

3. Received “Young oncologists Investigator Award” (YIA) from the International Society of Paediatric Oncology (SIOP) for the year 2016. (Annual Meeting, Dublin, Ireland).

4. Received Travel Grant from ESMO (European Society for Medical Oncology) to attendESMO Academy-2016, at Oxford, United Kingdom in August 2016.

5. Received the“ESMO–Image of the year Award” 2015 from European Society for Medical Oncology.

6. Received Travel grant from Department of Science & Technology to attend the 15th International Myeloma Workshop in Rome, Sept 2015. (presented two posters on Engraftment syndrome and POEMS syndrome)

7. Indian Society for Medical and Paediatric Oncology (ISMPO) Gold medal exam 2016, Chennai: 2nd runner-up prize.

8. Received Travel Grant from European Society for Medical Oncology (ESMO) to attend ESMO Asia Conference in Singapore in December 2015.

9. Received Travel Grant from European Society for Medical Oncology (ESMO) to attend Preceptorship meet in Gastric Cancer in August 2015 in Brussels, Belgium.

10. Honours in Anatomy, Physiology, Pharmacology, Preventive & Social Medicine, (MBBS)

11. Gold medal in ENT, Preventive & Social Medicine(MBBS)

Membership of Professional bodies:

1. Member: European Society for Medical Oncology, (ESMO).

2. Member: American Society of Clinical Oncology, (ASCO).

3. Member: Indian Society of Medical and Paediatric Oncology,(ISMPO)

4. Member: Paediatric Hemato-Oncology chapter of Inadian Academy of Paediatrics (PHO-IAP)

Selected Publications:

1. Pramanik R, Agarwala S, Gupta Y K, Bakhshi S; et al. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial JAMA Oncol. Published online April 6, 2017. doi:10.1001/jamaoncol.2017.0324

2. Pramanik R, Kumar L. 302PEngraftment syndrome during hematopoietic stem cell transplant: Analysis of 166 transplants from a tertiary care centre. Ann Oncol. 2015 Dec 1;26(suppl 9):ix89–ix89.

3. Pramanik R, Kumar L. Engraftment Syndrome During Auto HSCT in Plasma Cell Disorders: Retrospective Analysis of Consecutive Cases From a Tertiary Care Centre. Clin Lymphoma Myeloma Leuk. 2015 Sep 1;15:e159–60.

4. Pramanik R, Kumar L, Cyriac SL. Poems Syndrome: A Retrospective Analysis of Clinicopathological Profile and Treatment Outcomes of 43 Consecutive Cases from a Tertiary Cancer Centre in India. Clin Lymphoma Myeloma Leuk. 2015 Sep 1;15:e198–9.

5. Pramanik R, Gogia A, Sahoo RK. Manuscript entitled “Neutropenia due to Palbociclib : a word of caution”, with manuscript number ijmpo_158_15, is accepted for publication in the Indian Journal of Medical and paediatric Oncology, IJMPO”(July-Sept 2016 issue)

6. Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, et al. Complete response after autologous stem cell transplant in multiple myeloma. Cancer Med. 2014 Aug;3(4):939–46.

7. Kumar L, Pramanik R, Kumar S, Bhatla N, Malik S. Neoadjuvant chemotherapy in gynaecological cancers – Implications for staging. Best Pract Res ClinObstetGynaecol. 2015 Aug 1;29(6):790–801.

8. Gogia A, Khurana S, Paramanik R. Acute Myocardial Infarction after First Dose of Rituximab Infusion. Turk J Hematol. 2014 Mar;31(1):95–6.

9. Gogia A, Mehta P, Pramanik R, Gupta R .Chronic lymphocytic leukemia with massiveascites: An unusual presenting manifestation. South Asian J Cancer. 2014 Oct-Dec;3(4):235-236 PMID:25422818

10. Vallonthaiel AG, Kaur K, Jain D, Singh G, Tiwari D, Pramanik R, et al. Ewing Sarcoma of Urinary Bladder Showing EWSR1 Rearrangement on FISH Analysis and Unique Response to Chemotherapy. ClinGenitourinCancer , 2016 Apr;14(2):e183-6. doi:10.1016/j.clgc.2015.11.001. Epub 2015 Nov 11. PMID:266848127.

11. Image of the Month: November 2015 | Oncology Diagnosis Project | ESMO [Internet]. [cited 2015 Dec 2]. Available from: http://www.esmo.org/Career-Development/Young-Oncologists-Corner/Image-of-the-Month/November-2015-Image-of-the-Month

12. Ranjan A, PramanikR,Gupta R, Tanwar P, Bharti S et al ;Chronic Neutrophilic Leukemia: A Rare Chronic Myeloproliferative Disorder. International Journal of Hematology and Oncology 2014, Vol 24, Num 2 Page(s): 145-147

13. Gahlot GP, Mridha AR, Sable M, Sharma MC, Pramanik R, Kumar L.Solidpseudopapillary neoplasm of the ovary with metastases to the omentum and regional lymph nodes.IndianJPatholMicrobiol. 2016 Jul-Sep;59 (3):348-50. doi: 10.4103/0377- 4929.188107.PMID: 27510674

14. Gogia A, Mehta P, Pramanik R, Kumar .Isolated breast relapse mimicking breast cancer in elderly patient with acute lymphoblastic leukemia. R.Turk J Haematol. 2014 Jun;31(2):203-4. doi: 0.4274/tjh.2013.0270. Epub 2014 Jun 10. PMID:25035685

Dr. Prabhat Singh Malik

pinki.aiims@gmail.com (Ms. Pinki_CF) — Thu, 11 Jan 2018 12:58:37 +0530

Name: Dr. Prabhat Singh Malik

Designation: Assistant Professor of Medical Oncology

Affliation: Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi

E mail : drprabhatsm@gmail.com

Date of Birth: 10^th Nov 1979
Educational Qualification :

Degree	College/University	Subject	Year
MBBS	S.S.Medical College, Rewa, (M.P.), India	Medical graduation	1996-2001
MD	M.G.M. Medical College, Indore, (M.P.),India	Medicine	2004-2007
DM	All India Institute of Medical Sciences, New Delhi, India.	Medical Oncology	2009- June 2012

7. Teaching and Research Experience

Name of The post

Institute

Tenure

From To

Senior Research Associate (Pool Officer)

Dept of Medical Oncology, AIIMS,

New Delhi

1/5/2013- 29-7-14

Completed

Assistant Professor

Dept of Medical Oncology, AIIMS

New Delhi

30-7-14 - till date

8. Research specialization (Major scientific fields of interest)

Lung Cancer treatment
Molecular profiling and targeted therapies in NSCLC
Cancer immunology
Metronomic therapies and drug repositioning

9. Ongoing Research Projects
1. A Prospective, Randomized, Multicenter Study to Compare the Safety, Tolerability and efficacy of Bevacizumab (Zydus Cadila) with Bevacizumab (Avastin) in Non Small Cell Lung Cancer (Completed)
2. Validation of Thymidylate Synthetase and Folate Receptor alpha expression as predictive biomarkers for efficacy of Pemetrexed based chemotherapy in advanced non squamous NSCLC
3. Study of efficacy and safety of neoadjuvant chemotherapy in patients with stage 2B and 3 NSCLC: A pilot study
4. A Phase III Open label Randomized control study to compare efficacy and safety of Pemetrexed-Carboplatin versus Paclitaxel-Carboplatin as induction regimen in advanced Non-squamous Non-Small-Cell lung cancer

10. Important recent publications (last 5 years, with titles and References),

Indexed Journals

ASCENDing the anaplastic lymphoma kinase ladder: a tale of two C-nibs. Malik PS, Singh N.J Thorac Dis. 2016 Nov;8(11):E1514-E1516.PMID 5179416

2. Autologous stem cell transplantation for multiple myeloma: Long-term results. Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Patekar MB, Sahoo,RK, Malik PS, Sharma OD, Gupta R.Natl Med J India. 2016 Jul-Aug;29(4):192-199. PMID 28050994

3. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer. Malik PS, Jain D, Kumar L.Oncology. 2016;91Suppl 1:26-34. doi: 10.1159/000447578. PMID 27462979

4. Study of clinicopathological features, hormone immunoexpression and loss of ATRX and DAXX expression in pancreatic neuroendocrine tumors. Yadav R, Kakkar A, Sharma A, Malik PS, Sharma MC. Scand J Gastroenterol. 2016 Aug;51(8):994-9. PMID 27162024

5. Evaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study. Jain D, Iqbal S, Walia R, Malik P, Cyriac S, Mathur SR, Sharma MC, Madan K, Mohan A, Bhalla A, Pathy S, Kumar L, Guleria R. Indian J Med Res. 2016 Mar;143(3):308-14. PMID 27241644

6. Metastatic alveolar soft part sarcoma of the lung-a morphologic pitfall on cytology and aberrant CD10 expression on histology. Nambirajan A, Jain D, Malik P, Arava S, Mathur SR. DiagnCytopathol. 2015 Dec 22. doi: 10.1002/dc.23416. [Epub ahead of print]

7. Lung cancer: Prevalent trends and emerging concepts. Malik PS, Raina V. Indian J Med Res. 2015 Jan;141(1):5-7. PMID: 25857489

8. Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch. Malik PS, Raina V, André N. Front Oncol. 2014 Apr 10;4:76. PMID : 24782987

9. Underutilization of Curative Treatment among Patients with NSCLC: Experience from a Tertiary Care Centre in India. Malik PS, Malik A, Deo SVS, Mohan A, Mohanti BK, Raina V. Asian Pac J Cancer Prev. 2014;15(6):2875-8.PMID:26761917

10. Clinico-pathological Profile of Lung Cancer at AIIMS: A Changing Paradigm in India. Malik PS, Sharma MC, Mohanti BK, Shukla NK, Deo S, Mohan A, Kumar G, Raina V.Asian Pac J Cancer Prev. 2013;14(1):489-94.PMID:23534779

Comparison of BEAM vs LEAM regimen in autologous transplant for lymphoma at AIIMS. Sharma A, Kayal S, Iqbal S, Malik PS, Raina V. Springer Plus 2013;2:489
Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India.Kumar L, Malik PS, Prakash G, Prabu R, Radhakrishnan V, Katyal S, Hariprasad R.Ann Hematol. 2011 Nov;90(11):1317-28. Epub 2011 Mar 16. PMID:21409382

H1N1 infection in children with hematological malignancies.Malik PS, Broor S, Bakhshi S.Indian Pediatr. 2011 Dec;48(12):971-3.PMID:2225315

14. Renal impairment due to white-cell lysis after G-CSF and chemotherapy during pediatric autologous stem cell transplantation.Malik PS, Bakhshi S. J Pediatr Hematol Oncol. 2010 Jul;32(5):416-7.PMID: 20495480

15. Further progress in the treatment of multiple myeloma?Malik PS, Kumar L. Natl Med J India. 2009 Jan-Feb;22(1):25-7.PMID: 19761157

Principles of Drug Treatment of Cancer. Lalit Kumar, Prabhat Singh Malik. API Textbook of Medicine, 10^th edition.
Developments in Oncology. Lalit Kumar, Prabhat Singh Malik, API Textbook of Medicine, 10^th edition.

Book Chapters

Research Blog: https://www.researchgate.net/profile/Prabhat_Malik2

Dr Mayank Singh

pinki.aiims@gmail.com (Ms. Pinki_CF) — Fri, 07 Apr 2017 16:32:23 +0530

Name - Dr Mayank Singh

Designation- Associate Professor

Department- Medical Oncology (Lab) Dr BRAIRCH AIIMS New Delhi

Contact Information

Address- Department of Medical Oncology (Lab) Room no 411, 4^th Dr B.R.A.I.R.C.H AIIMS Ansari Nagar, New Delhi 110029

Email- Mayank.osu@gmail.com, Mayank_aiims97@yahoo.com

Area of Expertise-

Immunotherapy and its application in Cancer therapeutics.
Ubiquitin/Deubiquitin signaling and its application in cancer therapeutics.
Role of Histone Acetyl Transferases in inducing epigenetic modification in cancer microenvironment and its application in cancer and cancer stem cell Biology.
Liquid Biopsy and its application as a diagnostic tool.

Research Experience-

Assistant Professor Medical Oncology (Lab) Dr BRAIRCH AIIMS Delhi (2017-2020)
Senior Post doctorate researcher associate at Department of Radiation oncology, Comprehensive cancer center Ohio state university Columbus Ohio (2015-2017)
Post doctorate research associate at Cleveland clinic Lerner Research Institute Cleveland Ohio United states (2015)
Postdoctoral Research Associate at UTSW (University of Texas South Western) Medical Center in Dallas Texas USA (2009-2012)
Postdoctoral Research Associate at Penn state Herhey Medical center, Hershey Pennsylvania USA (2009)

Awards-

American Association for Cancer Research (AACR) Avon foundation Scholar in training Awardee at AACR 100th Annual Meeting, Denver ,Colorado 2009.
American association for cancer research (AACR) Scholar in training Awardee at AACR Translational Cancer Medicine 2008, Monterey CA, July 2008.
American Association for Cancer Research (AACR) Avon foundation Scholar in training Awardee at AACR special conference Advances in cancer research from laboratory to clinic Dead Sea, Jordan, March 2008.
Awarded CSIR NET SRF fellowship from Council of scientific and industrial research (CSIR) (2006-2009).
Awarded CSIR NET JRF fellowship from Council of scientific and industrial research (CSIR) (2004-2006).
Awarded GATE fellowship from Govt of India (2003).

Ongoing grants (Extramural and Intramural) sanctioned as PI (03)

Completed Project as PI (01)

S. No.	Title of the project	Funding agency	Duration (years)
1	Validation of USP37 as a prognostic and diagnostic marker in Osteosarcoma	AIIMS	2

Selected Publications

Stromberg BR, Singh M, Torres AE, Burrows AC, Pal D, Insinna C, Rhee Y, Dickson AS, Westlake CJ, Summers MK. The deubiquitinating enzyme USP37 enhances CHK1 activity to promote the cellular response to replication stress. J Biol Chem. 2021 Sep 10;297(4):101184. doi: 10.1016/j.jbc.2021.101184. Epub ahead of print. PMID: 34509474; PMCID: PMC8487067. (Shared First Authorship)

Sharma A, Singh M, Chauhan R, Malik PS, Khurana S, Mathur S, Kumar S, Sreenivas V, Kumar L. Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial. Gynecol Oncol. 2021 Aug;162(2):382-388. doi: 10.1016/j.ygyno.2021.05.025. Epub 2021 Jun 2. PMID: 34088513.

Singh M, Prasad CP, Shankar A. Publication Charges Associated with Quality Open Access (OA) Publishing and Its Impact on Low Middle Income Countries (LMICs), Time to Reframe Research Policies. Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2743-2747. doi: 10.31557/APJCP.2021.22.9.2743. PMID: 34582641. (Corresponding author)

Nisar S, Yousuf P, Masoodi T, Wani NA, Hashem S, Singh M, Sageena G, Mishra D, Kumar R, Haris M, Bhat AA, Macha MA. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. Int J Mol Sci. 2021 Apr 27;22(9):4584. doi: 10.3390/ijms22094584. PMID: 33925575; PMCID: PMC8123862.

Lone SN, Bhat AA, Wani NA, Karedath T, Hashem S, Nisar S, Singh M, Bagga P, Das BC, Bedognetti D, Reddy R, Frenneaux MP, El-Rifai W, Siddiqi MA, Haris M, Macha MA. miRNAs as novel immunoregulators in cancer. Semin Cell Dev Biol. 2021 Apr 26:S1084-9521(21)00086-0. doi: 10.1016/j.semcdb.2021.04.013 PMID: 33926791.

Nisar S, Bhat AA, Singh M, Karedath T, Rizwan A, Hashem S, Bagga P, Reddy R, Jamal F, Uddin S, Chand G, Bedognetti D, El-Rifai W, Frenneaux MP, Macha MA, Ahmed I and Haris M (2021) Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies. Front. Cell Dev. Biol. 9:617281. doi: 10.3389/fcell.2021.617281 (Shared First Authorship)

Cytokine-Chemokine Network Driven Metastasis in Esophageal Cancer; Promising Avenue for Targeted Therapy. Ajaz Ahmad Bhat, Sabah Nisar, Selma Maacha, Tatiana Carneiro-Lobo, Sabah Akhtar, Kodappully Sivaraman Siveen, Nisar Ahmad Wani, Arshi Rizwan, Puneet Bagga, Mayank Singh, Ravinder Reddy, Shahab Uddin, Jean-Charles Grivel, Gyan Chand, Michael P Frenneaux, Mushtaq A Siddiqi, Davide Bedognetti, Wael El-Rifai, Muzafar A. Macha, Mohammad Haris, Mol Cancer. 2021 Jan 4;20(1):2. doi: 10.1186/s12943-020-01294-3.

Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer. Sabah Nisar, Ajaz Ahmad Bhat, Sheema Hashem, Santosh Kumar Yadav, Arshi Rizwan, Mayank Singh, Puneet Bagga, Muzafar A Macha, Michael P Frenneaux, Ravinder Reddy, Mohammad Haris, J Transl Med. 2020 Dec 9;18(1):471. doi: 10.1186/s12967-020-02656-7.

Histone Acetyltransferase MOF Orchestrates Outcomes at the Crossroad of Oncogenesis, DNA Damage Response, Proliferation, and Stem Cell Development. Mayank Singh, Albino Bacolla, Shilpi Chaudhary, Clayton R. Hunt, Shruti Pandita, Ravi Chauhan, Ashna Gupta, John A. Tainer, Tej K. Pandita. Molecular and Cellular Biology Aug 2020, 40 (18) e00232-20; DOI: 10.1128/MCB.00232-20 (Corresponding author)

The Therapeutic and Preventive Efficacy of Curcumin and Its Derivatives in Esophageal Cancer. Komal Komal, Shilpi Chaudhary, Preeti Yadav, Raja Parmanik, Mayank Singh.Asian Pac J Cancer Prev. 2019 May 25;20(5):1329-1337. (Corresponding Author)

Environmental and occupational determinants of lung cancer. Abhishek Shankar, Anusha Dubey, Deepak Saini, Mayank Singh, Chandra Prakash Prasad, Shubham Roy, Sachidanand Jee Bharati, Minakshi Rinki, Navneet Singh, Tulika Seth, Meghal Khanna,Niharika Sethi, Sunil Kumar, Bhawna Sirohi, Anant Mohan, Randeep Guleria, Goura Kishor Rath. Transl Lung Cancer Res 2019;8(Suppl 1):S31-S49

Shankar A, Saini D, Dubey A, Roy S, Bharati SJ, Singh N, Khanna M, Prasad CP, Singh M, Kumar S, Sirohi B, Seth T, Rinki M, Mohan A, Guleria R, Rath GK. Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward. Transl Lung Cancer Res 2019;8(Suppl 1):S106-S121. doi: 10.21037/tlcr.2019.03.03

Cancer research in India: Challenges & opportunities. M Singh, CP Prasad, TD Singh, L Kumar. Indian J Med Res. 2018 Oct;148(4):362-365.

Targeting Inflammation in Ovarian Cancer Through Natural Antioxidants, Potential Therapeutic and Preventive Implications. M Singh, A Shankar, KS Dhiman, R Kotecha, GK Rath. Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2687-2690.

MOF suppresses replication stress and contribute to resolution of stalled replication forks. Singh DK, Pandita RK, Singh M, Chakraborty S, Hambarde S, Ramnarain D, Charaka V, Ahmed KM, Hunt CR, Pandita TK. Mol Cell Biol. 2018 Jan 3. pii: MCB.00484-17. doi: 10.1128/MCB.00484-17.

MOF phosphorylation by ATM regulates 53BP1-mediated DSB repair pathway choice. Arun Gupta, Clayton R. Hunt, Muralidhar L. Hegde, Sharmistha Chakraborty, Durga Udayakumar, Nobuo Horikoshi, Mayank Singh, Deepti B. Ramnarain, Walter N. Hittelman, Sarita Namjoshi, Aroumougame Asaithamby, Tapas K. Hazra, Thomas Ludwig, Raj K. Pandita, Jessica K. Tyler, and Tej K. Pandita. Cell Reports (cell press). 2014 Jul 10;8(1):177-89. doi: 10.1016/j.celrep.2014.05.044. Epub 2014 Jun 19.

Lamin A/C Depletion Enhances DNA Damage-Induced Stalled Replication Fork Arrest. Mayank Singh, Clayton R. Hunt, Raj K. Pandita, Rakesh Kumar, Chin-Rang Yang, Nobuo Horikoshi, Robert Bachoo, Sara Sarag, Michael D. Story, Jerry W. Shay, Simon N. Powell, Arun Gupta, Jessie Jeffery, Shruti Pandita, Benjamin P. C. Chen, Dorothee Deckbar, Markus, Qin Yang, Kum Kum Khanna, Howard J. Worman, Tej K. Pandita. Molecular and Cellular Biology. 2013 Mar;33(6):1210-22. doi: 10.1128/MCB.01676-12. Epub 2013 Jan 14.

T-cell-specific deletion of Mof blocks their differentiation and results in genomic instability in mice. Gupta A, Hunt CR, Pandita RK, Pae J, Komal komal , Singh M, Shay JW, Kumar R, Ariizumi K, Horikoshi N, Hittelman WN, Guha C, Ludwig T, Pandita TK. Mutagenesis. 2013 May; 28(3):263-70.

Human exonuclease 5 is a novel sliding exonuclease required for genome stability. Sparks JL, Kumar R, Mayank Singh, Wold MS, Pandita TK,Burgers PM. Journal of Biological Chemistry. 2012 Dec 14;287(51):42773-83.

Chromatin modifications and the DNA damage response to ionizing radiation. Kumar R, Horikoshi N, Mayank Singh, Gupta A, Misra HS, Albuquerque K, Hunt CR, Pandita TK. Frontiers in Oncology. 2012;2:214.

Bhadra MP, Horikoshi N, Pushpavallipvalli SN, Sarkar A, Bag I, Krishnan A, Lucchesi JC, Kumar R, Yang Q, Pandita RK, Singh M, Bhadra U, Eissenberg JC, Pandita TK. The role of MOF in the ionizing radiation response is conserved in Drosophila melanogaster. Chromosoma. 2011 Nov 10.ISSN : 0009-5915
SinghM,SinghNCurcumincounteractstheproliferativeeffectofestradiolinhumancervicalcarcinomacell lines. Molecular and Cellular Biochemistry, 2011 Jan;347(1-2):1-11. ISSN: 0300-8177.

Singh M, Singh N Molecular mechanism of curcumin induced cytotoxicityin cervical carcinoma cell lines. Molecular and Cellular Biochemistry,2009 May;325(1-2):107-19. ISSN: 0300-8177

Singh M, Singh N Induction of apoptosis byhydrogen peroxide in HPV 16 positive human cervical cancer cells: involvement ofmitochondrial pathway. Molecular and Cellular Biochemistry, 310: 57-65, 2008. ISSN: 0300-8177

Singh M, Sharma H, Singh N. Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion,7: 367-373, 2007.ISSN: 1567-7249

Orc id: https://orcid.org/0000-0003-0728-1936

Google Scholar- https://scholar.google.co.in/citations?user=5odRRS4AAAAJ&hl=en

Pub Med- https://www.ncbi.nlm.nih.gov/pubmed/?term=mayank+singh

Research Gate- https://www.researchgate.net/profile/Mayank_Singh32/publications

DR. SURENDER K. SHARAWAT

pinki.aiims@gmail.com (Ms. Pinki_CF) — Fri, 07 Apr 2017 16:23:43 +0530

DR. SURENDER K. SHARAWAT (PhD)

401, 4^TH FLOOR, DR.B.R. AMBEDKAR IRCH
ALL INDIA INSTITUTE OF MEDICAL SCIENCES

ANSARI NAGAR, NEW DELHI, 110029
sksharawat@gmail.com, sksharawat@aiims.edu

Area of Working:

Leukemia Genetics and Cytogenetics
Leukemia Transcriptomics (Long and circular non-coding RNA)
Leukemia Stem cells

Professional Experience:

Designation	Institute	Area of Working	Month/Year
Scientist-I	All India Institute of Medical Oncology New Delhi	Cancer Research	August 2016-Till date
Post-Doctoral Research Associates	National Institute of Immunology, New Delhi, INDIA	Cancer Stem cell biology	August 2015- January 2016
Post-Doctoral Research Associates	College of Medicine, University of Nebraska Medical Center, Omaha, USA	Stem Cell Research	March 2014- June 2015
Post-Doctoral Research Associates	National Institute of Immunology, New Delhi, INDIA	Cancer Stem Cell Biology	March 2013- March 2014

Educational Qualifications:

Degree	Institute	Specialization	Month/Year
Doctorate of Philosophy (PhD)	AllIndiaInstituteofMedicalSciences, NewDelhi,INDIA	Clinical Cancer Research	December, 2012
MasterofScience	M.D.University,Haryana,INDIA	Biotechnology	September 2004
BachelorofScience	M.D.University,Haryana,INDIA	LifeSciences	June 2002

Research Projects (Funded): Ongoing:

Project Title: “Role of HOTAIRM1 long non-coding RNA in chemo resistance of acute myeloid Leukemia”. Funded by DST, Budget 48.49 Lacs [Role: As PI, Duration 3 Years, 2019-2022]
Project Title: “The significance of UCA1 long non-coding RNA in pediatric acute myeloid leukemia. Funded by DST, Budget 10 Lacs [Role: As PI, Duration 2 Years, 2020-2022]
Project Title “Elucidation of the role of long non-coding RNA-Ginir as a biomarker in lung tumorigenesis”. Funding Agency: DBT; Duration: 03 years; Funds: 89 lakhs (In collaboration with NCCS, Pune (Role: Co-investigator)
Project Title “Evaluation of regulation of programmed death-ligand 1 (PD-L1) expression by microRNA in lung cancer”. Funding Agency: ICMR; Duration: 8/2019-8/2022; Funds: 47.64 lakhs (Role: Co-investigator)
Project Title “Study of Clinical Significance of Genetic Alterations and Feasibility of Adopting Children Oncology Group (COG) Risk-based Stratification of Wilms Tumor in Indian Children” Funding Agency: ICMR; Duration: 8/2020-8/2023 (Role: Co-P investigator)

List of Publications

Pandey M, Mukhopadhyay A, Sharawat SK, Kumar S. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer. Biochim Biophys Acta Rev Cancer 2021; 1876(1):188552. [PubMed PMID: 33892053]
Kumar S, Pandey M, Mir IA, Mukhopadhyay A, Sharawat SK, Jain D, Saikia J, Malik PS, Kumar S, Mohan A. Evaluation of the programmed death-ligand 1 mRNA expression and immunopositivity and their correlation with survival outcomes in Indian lung cancer patients. Human Cell 2021. [PubMed PMID: 34786661]
Sharawat SK*, Bansal AK*, Gupta R, Vishnubhatla S, Bakhshi S. Serial Evaluation of T cell Subsets in Paediatric Acute Myeloid Leukaemia- a Prospective Study (Accepted in Indian Journal of Hematology and Blood Transfusion, ahead of print) *Contributed Equally
Kumar S, Pandey M and Sharawat SK Biological Functions of Long Non-Coding RNAs and Circular RNAs in Small Cell Lung Cancer. Epigenomics. 2020 Oct;12(19):1751-1763[PubMed PMID: 33074037]
Sharawat SK Bansal AK, , Gupta R, Vishnubhatla S, Dhawan D, Bakhshi S. Regulatory T cells in pediatric AML are associated with disease load and their serial assessment suggests role in leukemogenesis. Am J Blood Res. 2020 Aug 25;10(4):90-96. eCollection 2020. [PubMed PMID: 32923088]
Kumar S, Sharawat SK, Ali A, Gaur V, Malik PS, Pandey M, Kumar S, Mohan A, Guleria R. Differential expression of circulating serum miR-1249-3p, miR-3195 and miR-3692-3p in non-small cell lung cancer. Human Cell. 2020 Jul;33(3):839-849 [PubMed PMID: 32215864]
Kumar S, Sharawat SK, Ali A, Gaur V, Malik PS, Kumar S, Mohan A, Guleria R. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients. Curr Probl Cancer 2020 Aug;44(4):100540. [PubMed PMID: 32007320]
Bhat AA, Younes SN, Raza SS, Zarif L, Nisar S, Ahmed I, Mir R, Kumar S, Sharawat SK, et al. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Mol Cancer. 2020 Mar 12;19(1):57. [PubMed PMID: 32164715]
Gaur V, Chaudhary S, Tyagi A, Agarwal S, Sharawat SK, Sarkar S, Singh H, Bakhshi S, Sharma P, Kumar S. Dysregulation of miRNA expression and their prognostic significance in pediatric cytogenetically normal acute myeloid leukemia. British J of Hematology, 2020 188: e90–e94. (IF 5.2) 145 [PubMed PMID: 32077100]
Baccarani M, Castagnetti F, Gugliotta G, Rosti G, Soverini S, Albeer A, Pfirrmann M, Sharawat SK, Kumar L. (for the International BCR-ABL Study Group) The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview,Leukemia 2019; 33, 1173–1183 (IF 12.03) [PubMed PMID: 30675008]
Kumar S and Sharawat SK. Epigenetic Regulators of PD-L1 Expression in Human Cancers. Transl Res. 2018; 202:129-145 [PubMed PMID: 30401465] (IF 4.915)
KumarS, Gaur V, Khurana S, Bose S, Kiran M, Sharawat SK. Proteomics – An Update on Recent Tools and Techniques. EC Proteomics and Bioinformatics 2.2 (2018): 57-73.
Sharawat SK*, Akhter M Z*, Kumar V*, Kochat V, Equbal Z, Ramakrishnan M , Kumar U, Mathur S, Kumar L, Mukhopadhyay A. Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype. Oncogene; 2018 Apr;37(16):2089-2103.[PubMed PMID: 29379166]*Contributed Equally
Sharawat SK, Vishnubhatla S, Bakhshi R, Raina V,Kumar L,Sharma A,Bakhshi S. High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in FLT3 internal tandem duplication (ITD) negative patients in adult acute myeloid leukaemia: a prospective pilot study from India. Indian J Med Res. 2016 May;143 (Supplement): S11-S16. [PubMed PMID: 27748272]
Sharawat SK, Vishnubhatla S, Bakhshi R, Raina V,Kumar L,Sharma A,Bakhshi S.Relative Receptor Tyrosine Kinases and Anti-Apoptotic Transcripts Hold Potential for Predicting Inferior Outcome in Adult Acute Myeloid Leukemia: A Prospective Pilot Study. Blood Cells Mol Dis. 2015 Jan;54(1):56-64[PubMed ID: 22420668]
Kesherwani V, Nandi SS, Sharawat SK, Shahshahan HR and Mishra PK. Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes. Mol Cell Biochem. 2015 Jun;404(1-2):241-50 [PubMed ID: 25763715]
Sharawat SK,Bakhshi R, Vishnubhatla S, Gupta R,Bakhshi S. FLT3-ITD Mutation in Relation to FLT3 Expression in Pediatric AML: a Prospective Study from India. Pediatr Hematol Oncol. 2014 Mar;31(2):131-7 [PMID: 24498869]
Sharawat SK, Raina V,Kumar L,Sharma A,Bakhshi R, Vishnubhatla S, Gupta R, Bakhshi S. Prospective Evaluation of Significance of Transcript and Flow-cytometric Expression of Bax in Acute Myeloid Leukemia. Hematology. 2014 Jan 3. [PMID:24620954]
Tilak TVSVGK, Sharawat SK, Gupta R, Agarwala S, Vishnubhatla S, Bakhshi S, Circulating T-Regulatory Cells in Neuroblastoma: a Pilot Prospective Study. PediatrHematolOncol. 2014 Mar 31 [PMID: 24684178]
Sharawat SK, Radhika Bakhshi, Vishnubhatla S, Gupta R, Bakhshi S. Bax/Bcl2 RMFI Ratio Predicts Better Induction Response in Pediatric Acute Myeloid Leukemia. Pediatric Blood and Cancer 2013 Aug; 60(8):E63-6 [PubMed ID: 23553948]
Tilak TVSVGK, Sharawat SK , Gupta R, Agarwala S, Vishnubhatla S, Bakhshi S, Circulating T-Regulatory Cells in PNET: a Prospective Study. Pediatric Blood and Cancer, 2013 [PubMed ID: 23997029]
Sharawat SK , Gupta R, Raina V,Kumar L,Sharma A,Iqbal S, Bakhshi R, Vishnubhatla S, Bakhshi S. Increased Co-Expression of c-KIT and FLT-3 Receptors on Myeloblasts: Independent Predictor of Poor Outcome in Acute Myeloid Leukemia. Cytometry B Clinical Cytometry 2013 [PubMed ID: 23740774]
Sharawat SK, Vishnubhatla S, Bakhshi R, Raina V,Kumar L,Sharma A,Bakhshi S. Relative Receptor Tyrosine Kinases and Anti-apoptotic Transcripts Hold Potential for Predicting Inferior Outcome in Adult Acute Myeloid Leukemia: A Prospective Pilot Study.Clin Lymphoma Myeloma Leuk 2013[PMID: 25065779]
Mandhaniya S, Iqbal S, Sharawat SK, Xess I, Bakhshi S. Diagnosis of invasive fungal infections using real-time PCR assay in paediatric acute leukaemia induction. Mycoses. 2012 Jul; 55(4):372-9 [PubMed ID: 22420668].
Gogia A, Sharawat SK, Kumar R, Sarkar C, Bakhshi S. Systemic Mastocytosis Associated With Childhood Acute Myeloid Leukemia. J PediatrHematolOncol. 2012 May 10 [PubMed ID: 22584780].
Sharawat SK,Bakhshi R, Vishnubhatla S, Bakhshi S. Mitochondrial D-loop variations in paediatric acute myeloid leukaemia: a potential prognostic marker. Br J Haematol. 2010 May; 149(3):391-8. Epub 2010 Mar 8 [PubMed ID: 20230407].
Gupta N, Gupta R, Sharawat SK, Bakhshi S. Childhood chronic myeloid leukemia with monocytosis. Indian J Pediatr. 2010 Oct; 77 (10):1143-5. Epub 2010 Sep 30 [PubMed ID: 20882436].

Educational Awards

Early career research Award (Serb-DST): 2019, Ministry of Science and Technology, Government of India New Delhi
First Prize for best oral presentation award by society of young scientist (SYS) 2012, AIIMS, New Delhi.
Young Investigator Travel Award by European Society of Medical Oncology (ESMO) 2012 in Vienna Austria.
Awarded Institute Fellowship grant (AIIMS) form 1st February 2012 to 31October, 2012
Awarded Junior Research Fellowship from Indian council of Medical Research (ICMR) and qualified examination in July 2005
Awarded Junior Research Fellowship from Indian council of Medical Research (ICMR) and qualified examination in July 2006 (1st February 2007 to 31 January 2009)
Awarded Senior research fellow from Indian council of Medical Research (ICMR) from 1st February 2009 to August 2012
Qualified CSIR-UGC JRF exam for National Eligibility Test (NET), conducted by Council for Scientific and Industrial Research (CSIR) and University Grant Commission (UGC) of INDIA in June 2005

DR. SAMPA GHOSE

pinki.aiims@gmail.com (Ms. Pinki_CF) — Fri, 07 Apr 2017 16:12:56 +0530

PERSONALINFORMATION

Name, Title: Sampa Ghose, Scientist II

Google Scholar:https://scholar.google.co.in/citations?user=DE4Tx24AAAAJ&hl=en

Date of birth: Jan 15^th 1975

Nationality, Origin: Indian, India

Marital Status, Children: married,1 (b: 2006)

Languages: Bengali, mother tongue; English, fluently; Hindi, fluently

Home Address: Ganga apartment, Arun Vihar, Sector 29, Noida, UP

Office Address: Department of Medical Oncology

All India Institute of Medical Sciences

Ansari Nagar, New Delhi, India

E-mail: sampaghose@gmail.com

Mobile: 91-9540946980

Website: https://www.aiims.edu/en/news/219-medical-oncology/6839-dr-sampa-ghose.html

2. EDUCATION

2004 PhD from University of Kalyani, West Bengal, India

1998 MSc (Master of Sciences) from Kalyani University, West Bengal, India

1996 BSc (Bachelor of Sciences) from Assam University, Assam, India

3. EMPLOYMENT HISTORY

2016- Till date Scientist II, Medical Oncology, All India Institute of Medical Sciences, New Delhi

2016-2016 Assistant Professor, Amity Institute of Molecular Medicine & Stem Cell Research

2013-2015 CSIR-Pool Scientist, Jawaharlal Nehru University, New Delhi

2009-2012 Post-doctoral Fellow, Vanderbilt University Medical Center, USA

2005- 2008 Post-doctoral Fellow, Medical University of South Carolina, USA

2003-2004 Research Associate, NIPGR, New Delhi, India.

4. INSTITUTIONAL RESPONSIBILITIES

Research, Teaching and Supervision of lab diagnostic services

5. LAB DIAGNOSTIC SERVICES

Galactomannan (GM), a component of cell wall of the aspergillus released during growth. To rule out the fungal infection, we detect GM antigen level in blood serum to diagnose invasive aspergillosis in cancer patients specially during chemotherapy and bone marrow transplantation.

New diagnostic service: Epstein - Barr virus (EBV) infection is associated with multiple types of cancer. Recently to diagnose EBV infection, started doing real-time PCR (qPCR) of EBV in Nasopharyngeal Carcinoma patients and also in bone marrow transplant patients regularly.

6. RESEARCH PROJECTS AS PI

2021-2024 DBT (Indo-Sweden Project)

2019-2021 Intramural project (AIIMS, New Delhi: A-721)

2016-2019 Extramural, Department of Science and Technology: SERB: YSS/2015/000092

2012-2015Council of Scientific & Industrial Research, CSIR: 13 (8600-A)/ 2012

7. CORE AREA(S) of RESEARCH INTEREST

- Endothelial dysfunction towards angiogenesis and cancer metastasis

- Impact of altered macrophages plasticity in Acute Myeloid Leukemia

- Invasive fungal infection in haematological malignancies

8. SUPERVISION OF JUNIOR RESEARCH FELLOW

JRFs: Aditya Tyagi (2017-2018), Preity Sharma (2018-2019)

9. MEMBERSHIPS/ REVIEWING WORK

- Reviewing work for Funding Bodies: Department of Science and Technology, India.

- Reviewing work for peer reviewed journals, including; BMC cancer, Scientific Report (Nature group)

10. MEMBERSHIPS OF SOCIETIES

Indian Association for Cancer Research (Life Time membership since 2017)

Indian Society of translational research (Life time member since 2018)

Research And Education Society of Molecular Oncology (Life time member since 2021)

11. PRIZES, AWARDS, FELLOWSHIPS

2021 Bursary/Awards winning Conference Proceeding (EASL, The International LiverCongress

2015 Young Scientist Department of Science and Technology (DST), India.

2012 Pool scientist award from Council of Scientific and Industrial Research

2012 Both oral and poster presentation at Keystone Symposia,

Pulmonary Vascular Disease Conference, USA.

12. RESEARCH OUTPUT

https://scholar.google.co.in/citations?user=DE4Tx24AAAAJ&hl=en

I. Selected Publications in international peer-reviewed journals

^#Corresponding Author

1. R Pramanik, S Arora, P Sharma, A Biswas, B Nayak, A Thakar, A Sharma, S Ghose^#(2021). Cell-free EBV DNA as a biomarker during clinical management of nasopharyngeal carcinoma in a non-endemic region. Journal of Medical Virology (In Press) (^#Corresponding Author)

2. S Sharma, MS Ghufran, B Das, B Roy, S. Ghose, S Biswas^* (2021). Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injury. Life Sciences- Elsevier doi.org/10.1016/j.lfs.2021.120119 IF: 5.037

3 Roy B, Ghose S, Biswas S (2021). Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma. Seminars in Cell & Developmental Biology26:S1084-9521(21)00079-3. doi: 10.1016/j.semcdb.2021.04.006.IF: 6.69

4. S Sharma MS Gufran, S Ghose, C. Bihari, S Biswas (2021). Survivin inhibition ameliorates liver fibrosis via inducing senescence in hepatic stellate cells. Journal of Hepatology –Elsevier 2021 vol. 75(2) | S389 IF: 20.85

5. Sharma S, Ghufran S M, Ghose S, Biswas S (2021).Cytoplasmic vacuolation with endoplasmic reticulum stress directs sorafenib induced non-apoptotic cell death in hepatic stellate cells Scientific Report 11: 3089: IF: 5.133

6. S Ghose^#, S Biswas^#, Kasturi Datta, Rakesh K. Tyagi (2018) Dynamic mechanism of Hyaluronan in liver endothelial cells towards angiogenesis. BMC Cancer18:648 IF: 4.4 (^#Corresponding Author)

7. S. Biswas and S. Ghose (2018). Divergent impact of Gender in Advancement of Liver injuries, diseases, and carcinogenesis. Frontier in Biosciences. Jan 1; 10:65-100, 2018 IF: 3.5

8. Andrea L. Frump, ArunimaDatta, Sampa Ghose, James West, Mark P. de Caestecker (2016) Genotype-phenotype effects of Bmpr2 mutations on disease severity in mouse models of pulmonary hypertension. Pulmonary Circulation, Nov 2; 6(4): 597-607. DOI: 10.1086/688930. IF: 6.364

9. Deepak Kotiya, Bharti Jaiswal, Sampa Ghose, Rachnakaul, Kasturi Datta, Rakesh K Tyagi (2016). Role of PXR in hepatic cancer: its influences on liver detoxification capacity and cancer progression.PLOS ONE, Oct 19; 11(10):e0164087IF: 4.4

10. Sampa Ghose, Yongfen Min, Laura DeBusk and P.Charles Lin (2015). δ-catenin regulates lymphatic endothelial cell motility and lymphangiogenesis through regulation of RhoGTPase.,PLOS ONE, Jan 30; 10(1): e0116338. IF: 4.4

11. Allison R Prewitt, Sampa Ghose, (Equal 1^st author) Andrea L Frump, Arumima Datta, Eric D Austin³, Anne K Kenworthy, Mark P de Caestecker (2015). Heterozygous Bone Morphogenetic Protein Receptor Type 2 Mutations Promote Src-Dependent Caveolar Trafficking Defects and Endothelial Dysfunction in the Pulmonary Vasculature.The Journal of Biological Chemistry (JBC),290 (2): 960–971. IF: 5.15

12. Annamalai Prakasam, Sampa Ghose, Natalia V. Oleinik, Yuri K. Peterson, Natalia I. Krupenko and Sergey A. Krupenko. (2014) JNK1/2 regulate BID by direct phosphorylation at Thr59. Cell Death and Disease (Nature Group),5, e1358; doi: 10.1038/cddis. 2014. 316. IF: 10.17

13. Suchandra Deb Roy; Inga I. Kramarenko; Sampa Ghose, Natalia V. Oleinik; Sergey A. Krupenko; Natalia I. Krupenko(2013) A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires the nuclear localization. PLOS ONE, Jul 30; 8 (7):e70062. IF: 4.4

14. Yongfen Min*, Sampa Ghose*(*Equal 1^st author), Kimberly Boelte, Jianhua Huang, Jingdong Li, Xiubao Ren, Li Yang and P. Charles Lin (2011) C/EBP-δ regulates VEGF-c induced lymphatic metastasis of lung cancer through HIf-1α transcription. Oncogene (Nature Group), 30(49):4901-4909. IF: 9.867

15. Sampa Ghose, Natalia O Oleinik, Natalia I Krupenko, Sergey A Krupenko (2009) FDH-induced JNK pathway diverge at JNK substrate level in cells with different p53 status. Molecular Cancer Research, 7(1):99-107. IF: 5.852